Gilles has dedicated over two decades to revolutionizing how companies in biopharma find partners and collaborate. As the CEO and co-founder of Inpart, Gilles has helped reshape the collaboration landscape for developing groundbreaking medicines. Since Inpart’s inception in 2010, he has overseen its transformation into a powerhouse that aids hundreds of life science companies, including 60% of top 50 pharma companies, in realizing their partnering strategies.

An engineer by training from Mines in Paris, Gilles resides in Lyon, France and his leadership continues to innovate the science partnering realm internationally.